drugset

drugset / Trial / NCT01669369

Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma

NCT01669369 ↗

Phase 4 Unknown 400 enrolled Sun Yat-sen University Guangdong Provincial Hospital of Traditional Chinese Medicine · collab Nanfang Hospital, Southern Medical University · collab Qilu Hospital of Shandong University · collab Shanghai 6th People's Hospital · collab Shenzhen Second People's Hospital · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Lithium Carbonate combined with neo-adjuvant chemotherapy improve the prognosis of osteosarcoma

Timeline

Start: 2013-01
Primary completion: 2023-12
Completion: 2023-12

Publications

Hattinger CM, Patrizio MP, Magagnoli F, Luppi S, Serra M. An update on emerging drugs in osteosarcoma: towards tailored therapies? Expert Opin Emerg Drugs. 2019 Sep;24(3):153-171. doi: 10.1080/14728214.2019.1654455. Epub 2019 Aug 14.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lithium Carbonate	Unknown	20 mg/kg	Oral
Subject	Lithium Carbonate	Unknown	25 mg/kg	Oral

Indications